LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.

    Kaminska, Halla / Szarpak, Lukasz / Kosior, Dariusz / Wieczorek, Wojciech / Szarpak, Agnieszka / Al-Jeabory, Mahdi / Gawel, Wladyslaw / Gasecka, Aleksandra / Jaguszewski, Milosz J / Jarosz-Chobot, Przemyslawa

    Acta diabetologica

    2021  Volume 58, Issue 8, Page(s) 1101–1110

    Abstract: ... meta-analysis of diabetes mellitus on in-hospital mortality in patients with COVID-19.: Methods: A systematic ... diabetes mellitus" OR "diabetes" OR "DM" AND "survival" OR "mortality" AND "SARS-CoV-2" OR "COVID-19".: Results ... therefore, patients with diabetes shall aim to reduce the exposure to the potential infection of COVID-19. ...

    Abstract Background: The novel coronavirus disease 2019 (COVID-19) has spread worldwide since the beginning of 2020, placing the heavy burden on the health systems all over the world. The population that particularly has been affected by the pandemic is the group of patients suffering from diabetes mellitus. Having taken the public health in considerations, we have decided to perform a systematic review and meta-analysis of diabetes mellitus on in-hospital mortality in patients with COVID-19.
    Methods: A systematic literature review (MEDLINE, EMBASE, Web of Science, Scopus, Cochrane) including all published clinical trials or observational studies published till December 10, 2020, was performed using following terms "diabetes mellitus" OR "diabetes" OR "DM" AND "survival" OR "mortality" AND "SARS-CoV-2" OR "COVID-19".
    Results: Nineteen studies were included out of the 7327 initially identified studies. Mortality of DM patients vs non-DM patients was 21.3 versus 6.1%, respectively (OR = 2.39; 95%CI: 1.65, 3.64; P < 0.001), while severe disease in DM and non-DM group varied and amounted to 34.8% versus 22.8% (OR = 1.43; 95%CI: 0.82, 2.50; P = 0.20). In the DM group, the complications were observed far more often when compared with non-DM group, both in acute respiratory distress (31.4 vs. 17.2%; OR = 2.38; 95%CI:1.80, 3.13; P < 0.001), acute cardiac injury (22.0% vs. 12.8%; OR = 2.59; 95%CI: 1.81, 3.73; P < 0.001), and acute kidney injury (19.1 vs. 10.2%; OR = 1.97; 95%CI: 1.36, 2.85; P < 0.001).
    Conclusions: Based on the findings, we shall conclude that diabetes is an independent risk factor of the severity of COVID-19 in-hospital settings; therefore, patients with diabetes shall aim to reduce the exposure to the potential infection of COVID-19.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; COVID-19/mortality ; COVID-19/therapy ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/mortality ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Pandemics ; Risk Factors ; SARS-CoV-2
    Language English
    Publishing date 2021-03-20
    Publishing country Germany
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 1097676-0
    ISSN 1432-5233 ; 0940-5429
    ISSN (online) 1432-5233
    ISSN 0940-5429
    DOI 10.1007/s00592-021-01701-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.

    Tan, Elinor / Song, Jialu / Deane, Adam M / Plummer, Mark P

    Chest

    2020  Volume 159, Issue 2, Page(s) 524–536

    Abstract: ... that reported in-hospital mortality rate of adult patients (age >18 years) with confirmed COVID-19 admitted ... of deaths and risk factors for patients who are admitted to ICUs with severe COVID-19?: Study design and ... patients with COVID-19 who are admitted to the ICU require substantial organ support and prolonged ICU and ...

    Abstract Background: The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented burden on the delivery of intensive care services worldwide.
    Research question: What is the global point estimate of deaths and risk factors for patients who are admitted to ICUs with severe COVID-19?
    Study design and methods: In this systematic review and meta-analysis Medline, Embase, and the Cochrane library were searched up to August 1, 2020. Pooled prevalence of participant characteristics, clinical features, and outcome data was calculated with the use of random effects models. Subgroup analyses were based on geographic distribution, study type, quality assessment, sample size, end date, and patient disposition. Studies that reported in-hospital mortality rate of adult patients (age >18 years) with confirmed COVID-19 admitted to an ICU met study eligibility criteria. Critical evaluation was performed with the Newcastle Ottawa Scale for nonrandomized studies.
    Results: Forty-five studies with 16,561 patients from 17 countries across four continents were included. Patients with COVID-19 who were admitted to ICUs had a mean age of 62.6 years (95% CI, 60.4-64.7). Common comorbidities included hypertension (49.5%; 95% CI, 44.9-54.0) and diabetes mellitus (26.6%; 95% CI, 22.7-30.8). More than three-quarters of cases experienced the development of ARDS (76.1%; 95% CI, 65.7-85.2). Invasive mechanical ventilation was required in 67.7% (95% CI, 59.1-75.7) of case, vasopressor support in 65.9% (95% CI, 52.4-78.4) of cases, renal replacement therapy in 16.9% (95% CI, 12.1-22.2) of cases, and extracorporeal membrane oxygenation in 6.4% (95% CI, 4.1-9.1) of cases. The duration of ICU and hospital admission was 10.8 days (95% CI, 9.3-18.4) and 19.1 days (95% CI, 16.3-21.9), respectively, with in-hospital mortality rate of 28.1% (95% CI, 23.4-33.0; I
    Interpretation: Critically ill patients with COVID-19 who are admitted to the ICU require substantial organ support and prolonged ICU and hospital level care. The pooled estimate of global death from severe COVID-19 is <1 in 3.
    MeSH term(s) Acute Kidney Injury/physiopathology ; Acute Kidney Injury/therapy ; Anti-Bacterial Agents/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/epidemiology ; COVID-19/mortality ; COVID-19/physiopathology ; COVID-19/therapy ; Coinfection/physiopathology ; Coinfection/therapy ; Comorbidity ; Diabetes Mellitus/epidemiology ; Extracorporeal Membrane Oxygenation/statistics & numerical data ; Glucocorticoids/therapeutic use ; Heart Diseases/physiopathology ; Heart Diseases/therapy ; Hospital Mortality ; Hospitalization ; Humans ; Hypertension/epidemiology ; Immunoglobulins, Intravenous/therapeutic use ; Immunologic Factors/therapeutic use ; Intensive Care Units ; Length of Stay/statistics & numerical data ; Renal Replacement Therapy/statistics & numerical data ; Respiration, Artificial/statistics & numerical data ; Respiratory Distress Syndrome/physiopathology ; Respiratory Distress Syndrome/therapy ; Risk Factors ; SARS-CoV-2 ; Severity of Illness Index ; Thrombosis/physiopathology ; Thrombosis/therapy ; Vasoconstrictor Agents/therapeutic use
    Chemical Substances Anti-Bacterial Agents ; Antiviral Agents ; Glucocorticoids ; Immunoglobulins, Intravenous ; Immunologic Factors ; Vasoconstrictor Agents
    Keywords covid19
    Language English
    Publishing date 2020-10-15
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2020.10.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top